4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-020302
Chief Financial Officer sold 10,000 shares at $42.54 ($425,400)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-03-10 | Option exercise | +10,000 | $6.32 | $63,200 | 31,604 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2021-03-10 | Sale | −10,000 | $42.54 | $425,400 | 21,604 | D: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $42.54 · $425,400 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2021-03-10 | Option exercise · Stock Option (Right to Buy) | −10,000 | 45,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…